Dendreon
Pre-clinicalBiotechnology company focused on developing cancer immunotherapies, notably Provenge for prostate cancer.
Founded
1992
Focus
Cell & Gene Therapy
About
Biotechnology company focused on developing cancer immunotherapies, notably Provenge for prostate cancer.
Funding History
4Total raised: $235M
PIPE$125MUndisclosedJun 15, 2007
IPO$80MUndisclosedJun 30, 2000
Series B$25MMorningside VenturesJun 15, 2000
Series A$5MARCH Venture PartnersJun 15, 1997
Company Info
TypePrivate
Founded1992
LocationSeal Beach, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile